Free Trial
→ New “Trump” currency proposed in DC (From Paradigm Press) (Ad) Buy EVAX Stock  Free EVAX Stock Alerts

Evaxion Biotech A/S (EVAX) SEC Filings & 10K Form

Evaxion Biotech A/S logo
$1.85 +0.09 (+5.11%)
Closing price 03/31/2025 04:00 PM Eastern
Extended Trading
$1.95 +0.10 (+5.41%)
As of 03/31/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Evaxion Biotech A/S SEC Filings

Export to Excel
DateFilerForm TypeView
03/27/2025
7:15 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
3:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2025
3:45 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/24/2025
11:15 PM		Evaxion Biotech A/S (Filer)
Form EFFECT
03/04/2025
7:15 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:15 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
4:44 PM		ARMISTICE CAPITAL, LLC (Filed by)
Evaxion Biotech A/S (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:15 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2025
7:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
3:15 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
5:33 AM		Evaxion Biotech A/S (Filer)
Form 424B4
01/30/2025
7:05 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2025
11:15 PM		Evaxion Biotech A/S (Filer)
Form EFFECT
01/28/2025
3:34 PM		Evaxion Biotech A/S (Filer)
Form F-1/A
01/28/2025
7:26 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
7:25 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:16 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/15/2025
7:10 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
3:15 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2025
7:15 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/07/2025
8:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:15 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
4:09 PM		Evaxion Biotech A/S (Filer)
Form F-1/A
12/17/2024
7:16 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
7:10 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/09/2024
8:01 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2024
3:53 PM		Evaxion Biotech A/S (Filer)
Form F-1/A
12/03/2024
5:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
8:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
6:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
6:04 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2024
3:09 PM		Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
Form SC 13G/A
10/31/2024
9:20 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
8:10 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
10:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
6:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2024
6:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/26/2024
7:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
7:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
09/16/2024
6:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
7:22 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
7:24 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2024
7:30 AM		Evaxion Biotech A/S (Filer)
Form 424B4
08/22/2024
11:15 PM		Evaxion Biotech A/S (Filer)
Form EFFECT
08/20/2024
7:45 AM		Evaxion Biotech A/S (Filer)
Form F-1/A
08/19/2024
4:31 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
6:15 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
6:45 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/08/2024
7:32 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
3:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
7:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
3:31 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
7:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
3:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
3:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/26/2024
7:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
3:50 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
3:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
8:13 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
8:25 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
7:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
8:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
4:05 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
4:29 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
4:30 PM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
8:30 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
7:00 AM		Evaxion Biotech A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:EVAX) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Retirement Nightmare? It’s Already Happening.
The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...
Investors Alley | Sponsored
New “Trump” currency proposed in DC
A former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...
Paradigm Press | Sponsored
Live Footage From Elon Musk’s “Area 51”
What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...
Brownstone Research | Sponsored
Termination: 18F (read immediately)
Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...
Altimetry | Sponsored
10X Bigger than AI, quantum, EVs, crypto, and robotics combined?
World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...
Stansberry Research | Sponsored
“Massive Financial Reset Is Coming”
The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...
InvestorPlace | Sponsored
Gold Hits $3,000… Here’s How You Can Get More for Under $20
With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...
The Oxford Club | Sponsored